nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—HTR2C—bipolar disorder	0.174	0.235	CbGaD
Doxepin—HTR1A—bipolar disorder	0.169	0.228	CbGaD
Doxepin—SLC6A4—bipolar disorder	0.144	0.194	CbGaD
Doxepin—DRD2—bipolar disorder	0.144	0.193	CbGaD
Doxepin—HTR2A—bipolar disorder	0.111	0.149	CbGaD
Doxepin—SLC6A2—locus ceruleus—bipolar disorder	0.00596	0.0787	CbGeAlD
Doxepin—ORM1—saliva—bipolar disorder	0.00412	0.0545	CbGeAlD
Doxepin—HTR2A—locus ceruleus—bipolar disorder	0.00358	0.0473	CbGeAlD
Doxepin—HTR2C—telencephalic ventricle—bipolar disorder	0.00338	0.0447	CbGeAlD
Doxepin—SLC6A2—autonomic nervous system—bipolar disorder	0.00317	0.0418	CbGeAlD
Doxepin—HTR1A—telencephalic ventricle—bipolar disorder	0.00285	0.0376	CbGeAlD
Doxepin—DRD2—telencephalic ventricle—bipolar disorder	0.00257	0.034	CbGeAlD
Doxepin—CYP2C19—urine—bipolar disorder	0.00243	0.0321	CbGeAlD
Doxepin—CYP1A2—urine—bipolar disorder	0.00198	0.0262	CbGeAlD
Doxepin—HTR2A—autonomic nervous system—bipolar disorder	0.0019	0.0251	CbGeAlD
Doxepin—CYP2C9—urine—bipolar disorder	0.00188	0.0249	CbGeAlD
Doxepin—HTR2A—telencephalic ventricle—bipolar disorder	0.0017	0.0224	CbGeAlD
Doxepin—HTR2A—urine—bipolar disorder	0.00155	0.0205	CbGeAlD
Doxepin—SLC6A4—blood plasma—bipolar disorder	0.00153	0.0202	CbGeAlD
Doxepin—CYP3A4—urine—bipolar disorder	0.00144	0.019	CbGeAlD
Doxepin—CYP2D6—urine—bipolar disorder	0.00141	0.0187	CbGeAlD
Doxepin—HTR1A—blood plasma—bipolar disorder	0.00136	0.0179	CbGeAlD
Doxepin—CYP2C19—blood plasma—bipolar disorder	0.00127	0.0167	CbGeAlD
Doxepin—Olopatadine—S100B—bipolar disorder	0.00114	0.157	CrCbGaD
Doxepin—CYP1A2—blood plasma—bipolar disorder	0.00103	0.0137	CbGeAlD
Doxepin—CYP2C9—blood plasma—bipolar disorder	0.000982	0.013	CbGeAlD
Doxepin—ADRA2A—blood plasma—bipolar disorder	0.000952	0.0126	CbGeAlD
Doxepin—CHRM4—nervous system—bipolar disorder	0.000928	0.0123	CbGeAlD
Doxepin—HTR6—nervous system—bipolar disorder	0.00083	0.011	CbGeAlD
Doxepin—HTR2A—blood plasma—bipolar disorder	0.000809	0.0107	CbGeAlD
Doxepin—HTR2B—adrenal cortex—bipolar disorder	0.000769	0.0102	CbGeAlD
Doxepin—HRH2—nervous system—bipolar disorder	0.000759	0.01	CbGeAlD
Doxepin—CYP3A4—blood plasma—bipolar disorder	0.000749	0.00989	CbGeAlD
Doxepin—CYP2D6—blood plasma—bipolar disorder	0.000737	0.00974	CbGeAlD
Doxepin—CHRM5—nervous system—bipolar disorder	0.000725	0.00958	CbGeAlD
Doxepin—CHRM4—brain—bipolar disorder	0.000709	0.00937	CbGeAlD
Doxepin—ADRA1B—nervous system—bipolar disorder	0.000663	0.00875	CbGeAlD
Doxepin—ADRA1D—nervous system—bipolar disorder	0.000648	0.00856	CbGeAlD
Doxepin—HTR6—brain—bipolar disorder	0.000635	0.00838	CbGeAlD
Doxepin—ADRA2C—adrenal cortex—bipolar disorder	0.000605	0.008	CbGeAlD
Doxepin—HRH2—brain—bipolar disorder	0.00058	0.00766	CbGeAlD
Doxepin—CHRM5—brain—bipolar disorder	0.000554	0.00732	CbGeAlD
Doxepin—HTR2B—thyroid gland—bipolar disorder	0.000536	0.00708	CbGeAlD
Doxepin—ORM1—nervous system—bipolar disorder	0.000534	0.00705	CbGeAlD
Doxepin—ABCB1—blood plasma—bipolar disorder	0.00053	0.007	CbGeAlD
Doxepin—ADRA1B—brain—bipolar disorder	0.000506	0.00669	CbGeAlD
Doxepin—CHRM2—nervous system—bipolar disorder	0.000498	0.00657	CbGeAlD
Doxepin—ADRA1D—brain—bipolar disorder	0.000495	0.00654	CbGeAlD
Doxepin—CHRM3—thyroid gland—bipolar disorder	0.000482	0.00637	CbGeAlD
Doxepin—HTR2C—nervous system—bipolar disorder	0.00048	0.00634	CbGeAlD
Doxepin—SLC6A4—nervous system—bipolar disorder	0.000455	0.00601	CbGeAlD
Doxepin—CHRM1—nervous system—bipolar disorder	0.000453	0.00598	CbGeAlD
Doxepin—HTR2B—nervous system—bipolar disorder	0.000451	0.00595	CbGeAlD
Doxepin—Orphenadrine—GRIN1—bipolar disorder	0.000407	0.0563	CrCbGaD
Doxepin—Amitriptyline—NTRK2—bipolar disorder	0.000407	0.0562	CrCbGaD
Doxepin—CHRM3—nervous system—bipolar disorder	0.000405	0.00535	CbGeAlD
Doxepin—HTR1A—nervous system—bipolar disorder	0.000404	0.00533	CbGeAlD
Doxepin—SLC6A2—nervous system—bipolar disorder	0.0004	0.00529	CbGeAlD
Doxepin—CHRM2—brain—bipolar disorder	0.00038	0.00502	CbGeAlD
Doxepin—HTR1A—cerebellum—bipolar disorder	0.00038	0.00502	CbGeAlD
Doxepin—ADRA1A—nervous system—bipolar disorder	0.000372	0.00492	CbGeAlD
Doxepin—HTR2C—brain—bipolar disorder	0.000367	0.00484	CbGeAlD
Doxepin—CYP1A2—thyroid gland—bipolar disorder	0.000366	0.00483	CbGeAlD
Doxepin—DRD2—nervous system—bipolar disorder	0.000365	0.00482	CbGeAlD
Doxepin—KCNH2—nervous system—bipolar disorder	0.00036	0.00475	CbGeAlD
Doxepin—ADRA2C—nervous system—bipolar disorder	0.000355	0.00468	CbGeAlD
Doxepin—ADRA1A—cerebellum—bipolar disorder	0.00035	0.00463	CbGeAlD
Doxepin—SLC6A4—brain—bipolar disorder	0.000348	0.00459	CbGeAlD
Doxepin—CHRM1—brain—bipolar disorder	0.000346	0.00457	CbGeAlD
Doxepin—HTR2B—brain—bipolar disorder	0.000344	0.00455	CbGeAlD
Doxepin—DRD2—cerebellum—bipolar disorder	0.000343	0.00453	CbGeAlD
Doxepin—KCNH2—cerebellum—bipolar disorder	0.000338	0.00447	CbGeAlD
Doxepin—ADRA2A—thyroid gland—bipolar disorder	0.000337	0.00444	CbGeAlD
Doxepin—ADRA2C—cerebellum—bipolar disorder	0.000334	0.00441	CbGeAlD
Doxepin—CHRM3—brain—bipolar disorder	0.00031	0.00409	CbGeAlD
Doxepin—HTR1A—brain—bipolar disorder	0.000309	0.00408	CbGeAlD
Doxepin—SLC6A2—brain—bipolar disorder	0.000306	0.00404	CbGeAlD
Doxepin—HRH1—nervous system—bipolar disorder	0.000288	0.00381	CbGeAlD
Doxepin—ADRA1A—brain—bipolar disorder	0.000285	0.00376	CbGeAlD
Doxepin—ADRA2A—nervous system—bipolar disorder	0.000283	0.00374	CbGeAlD
Doxepin—DRD2—brain—bipolar disorder	0.000279	0.00368	CbGeAlD
Doxepin—KCNH2—brain—bipolar disorder	0.000275	0.00363	CbGeAlD
Doxepin—ADRA2C—brain—bipolar disorder	0.000271	0.00358	CbGeAlD
Doxepin—ABCB1—adrenal cortex—bipolar disorder	0.000269	0.00356	CbGeAlD
Doxepin—ADRA2A—cerebellum—bipolar disorder	0.000266	0.00352	CbGeAlD
Doxepin—Amitriptyline—NTRK1—bipolar disorder	0.000251	0.0347	CrCbGaD
Doxepin—HTR2A—nervous system—bipolar disorder	0.000241	0.00318	CbGeAlD
Doxepin—HTR2A—cerebellum—bipolar disorder	0.000226	0.00299	CbGeAlD
Doxepin—CYP3A4—nervous system—bipolar disorder	0.000223	0.00294	CbGeAlD
Doxepin—HRH1—brain—bipolar disorder	0.00022	0.00291	CbGeAlD
Doxepin—CYP2D6—nervous system—bipolar disorder	0.000219	0.0029	CbGeAlD
Doxepin—ADRA2A—brain—bipolar disorder	0.000216	0.00286	CbGeAlD
Doxepin—CYP2D6—cerebellum—bipolar disorder	0.000206	0.00272	CbGeAlD
Doxepin—ABCB1—thyroid gland—bipolar disorder	0.000188	0.00248	CbGeAlD
Doxepin—Thiothixene—DRD1—bipolar disorder	0.000185	0.0255	CrCbGaD
Doxepin—HTR2A—brain—bipolar disorder	0.000184	0.00243	CbGeAlD
Doxepin—CYP2D6—brain—bipolar disorder	0.000168	0.00221	CbGeAlD
Doxepin—Thiothixene—HTR2C—bipolar disorder	0.000158	0.0218	CrCbGaD
Doxepin—ABCB1—nervous system—bipolar disorder	0.000158	0.00208	CbGeAlD
Doxepin—Thiothixene—HTR1A—bipolar disorder	0.000153	0.0212	CrCbGaD
Doxepin—Cyclobenzaprine—HTR2A—bipolar disorder	0.000151	0.0209	CrCbGaD
Doxepin—ABCB1—cerebellum—bipolar disorder	0.000148	0.00196	CbGeAlD
Doxepin—Chlorprothixene—DRD3—bipolar disorder	0.000148	0.0205	CrCbGaD
Doxepin—Chlorprothixene—DRD1—bipolar disorder	0.000145	0.0201	CrCbGaD
Doxepin—Promazine—DRD4—bipolar disorder	0.000135	0.0186	CrCbGaD
Doxepin—Thiothixene—DRD2—bipolar disorder	0.00013	0.018	CrCbGaD
Doxepin—Trimipramine—SLC6A3—bipolar disorder	0.000127	0.0176	CrCbGaD
Doxepin—Clomipramine—HTR2C—bipolar disorder	0.000125	0.0173	CrCbGaD
Doxepin—Chlorprothixene—HTR2C—bipolar disorder	0.000124	0.0172	CrCbGaD
Doxepin—Nortriptyline—HTR2C—bipolar disorder	0.000122	0.0169	CrCbGaD
Doxepin—ABCB1—brain—bipolar disorder	0.000121	0.00159	CbGeAlD
Doxepin—Nortriptyline—HTR1A—bipolar disorder	0.000119	0.0164	CrCbGaD
Doxepin—Trimipramine—HTR2C—bipolar disorder	0.000115	0.0159	CrCbGaD
Doxepin—Promazine—DRD1—bipolar disorder	0.000114	0.0157	CrCbGaD
Doxepin—Trimipramine—HTR1A—bipolar disorder	0.000112	0.0154	CrCbGaD
Doxepin—Desipramine—SLC6A3—bipolar disorder	0.000111	0.0154	CrCbGaD
Doxepin—Clomipramine—SLC6A4—bipolar disorder	0.000104	0.0143	CrCbGaD
Doxepin—Chlorprothixene—DRD2—bipolar disorder	0.000103	0.0142	CrCbGaD
Doxepin—Nortriptyline—SLC6A4—bipolar disorder	0.000101	0.014	CrCbGaD
Doxepin—Amitriptyline—DRD3—bipolar disorder	0.000101	0.0139	CrCbGaD
Doxepin—Thiothixene—HTR2A—bipolar disorder	0.000101	0.0139	CrCbGaD
Doxepin—Nortriptyline—DRD2—bipolar disorder	0.000101	0.0139	CrCbGaD
Doxepin—Desipramine—HTR2C—bipolar disorder	0.000101	0.0139	CrCbGaD
Doxepin—Desipramine—HTR1A—bipolar disorder	9.76e-05	0.0135	CrCbGaD
Doxepin—Promazine—HTR2C—bipolar disorder	9.74e-05	0.0135	CrCbGaD
Doxepin—Trimipramine—SLC6A4—bipolar disorder	9.53e-05	0.0132	CrCbGaD
Doxepin—Trimipramine—DRD2—bipolar disorder	9.48e-05	0.0131	CrCbGaD
Doxepin—Imipramine—SLC6A3—bipolar disorder	9.45e-05	0.0131	CrCbGaD
Doxepin—Promethazine—DRD2—bipolar disorder	9.12e-05	0.0126	CrCbGaD
Doxepin—Imipramine—HTR2C—bipolar disorder	8.53e-05	0.0118	CrCbGaD
Doxepin—Amitriptyline—HTR2C—bipolar disorder	8.47e-05	0.0117	CrCbGaD
Doxepin—Desipramine—SLC6A4—bipolar disorder	8.33e-05	0.0115	CrCbGaD
Doxepin—Desipramine—DRD2—bipolar disorder	8.29e-05	0.0114	CrCbGaD
Doxepin—Imipramine—HTR1A—bipolar disorder	8.28e-05	0.0114	CrCbGaD
Doxepin—Amitriptyline—HTR1A—bipolar disorder	8.23e-05	0.0114	CrCbGaD
Doxepin—Promazine—DRD2—bipolar disorder	8.03e-05	0.0111	CrCbGaD
Doxepin—Clomipramine—HTR2A—bipolar disorder	7.96e-05	0.011	CrCbGaD
Doxepin—Chlorprothixene—HTR2A—bipolar disorder	7.92e-05	0.0109	CrCbGaD
Doxepin—Nortriptyline—HTR2A—bipolar disorder	7.78e-05	0.0107	CrCbGaD
Doxepin—Trimipramine—HTR2A—bipolar disorder	7.32e-05	0.0101	CrCbGaD
Doxepin—Imipramine—SLC6A4—bipolar disorder	7.07e-05	0.00976	CrCbGaD
Doxepin—Promethazine—HTR2A—bipolar disorder	7.05e-05	0.00974	CrCbGaD
Doxepin—Imipramine—DRD2—bipolar disorder	7.03e-05	0.00971	CrCbGaD
Doxepin—Amitriptyline—SLC6A4—bipolar disorder	7.02e-05	0.0097	CrCbGaD
Doxepin—Amitriptyline—DRD2—bipolar disorder	6.98e-05	0.00965	CrCbGaD
Doxepin—Desipramine—HTR2A—bipolar disorder	6.4e-05	0.00885	CrCbGaD
Doxepin—Promazine—HTR2A—bipolar disorder	6.2e-05	0.00857	CrCbGaD
Doxepin—Imipramine—HTR2A—bipolar disorder	5.43e-05	0.0075	CrCbGaD
Doxepin—Amitriptyline—HTR2A—bipolar disorder	5.4e-05	0.00746	CrCbGaD
Doxepin—ABCB1—Metabolism—DPYD—bipolar disorder	6.87e-06	3.95e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—S100B—bipolar disorder	6.86e-06	3.94e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—DRD4—bipolar disorder	6.85e-06	3.93e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—DRD4—bipolar disorder	6.83e-06	3.92e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—NTRK1—bipolar disorder	6.81e-06	3.91e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—POMC—bipolar disorder	6.78e-06	3.9e-05	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—POMC—bipolar disorder	6.77e-06	3.89e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—NTRK1—bipolar disorder	6.77e-06	3.89e-05	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—POMC—bipolar disorder	6.76e-06	3.88e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CLOCK—bipolar disorder	6.75e-06	3.88e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—DRD1—bipolar disorder	6.75e-06	3.88e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—HTR2C—bipolar disorder	6.75e-06	3.88e-05	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—POMC—bipolar disorder	6.74e-06	3.87e-05	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—POMC—bipolar disorder	6.72e-06	3.86e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—HTR2A—bipolar disorder	6.71e-06	3.86e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—NRG1—bipolar disorder	6.7e-06	3.85e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CLOCK—bipolar disorder	6.69e-06	3.84e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—ADCY2—bipolar disorder	6.67e-06	3.83e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—COMT—bipolar disorder	6.67e-06	3.83e-05	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—POMC—bipolar disorder	6.65e-06	3.82e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TCF7L2—bipolar disorder	6.65e-06	3.82e-05	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—POMC—bipolar disorder	6.63e-06	3.81e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—S100B—bipolar disorder	6.62e-06	3.8e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—MAOA—bipolar disorder	6.62e-06	3.8e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—NTRK1—bipolar disorder	6.59e-06	3.79e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—S100B—bipolar disorder	6.58e-06	3.78e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—TPH2—bipolar disorder	6.58e-06	3.78e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—TSHB—bipolar disorder	6.58e-06	3.78e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CACNB2—bipolar disorder	6.58e-06	3.78e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—ADCY2—bipolar disorder	6.56e-06	3.77e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NTRK2—bipolar disorder	6.56e-06	3.77e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—ADCY2—bipolar disorder	6.55e-06	3.76e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TCF7L2—bipolar disorder	6.54e-06	3.76e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—CACNA1C—bipolar disorder	6.54e-06	3.76e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—DRD3—bipolar disorder	6.54e-06	3.75e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—ADCY2—bipolar disorder	6.53e-06	3.75e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TCF7L2—bipolar disorder	6.53e-06	3.75e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—TSHB—bipolar disorder	6.52e-06	3.75e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—TPH2—bipolar disorder	6.52e-06	3.75e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CACNB2—bipolar disorder	6.52e-06	3.75e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—NR1D1—bipolar disorder	6.51e-06	3.74e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—ADCY2—bipolar disorder	6.51e-06	3.74e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—GSK3A—bipolar disorder	6.51e-06	3.74e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TCF7L2—bipolar disorder	6.51e-06	3.74e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—DRD2—bipolar disorder	6.5e-06	3.73e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—HTR2A—bipolar disorder	6.49e-06	3.73e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TCF7L2—bipolar disorder	6.49e-06	3.73e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—NTRK1—bipolar disorder	6.48e-06	3.73e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—DRD2—bipolar disorder	6.48e-06	3.72e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—DPYD—bipolar disorder	6.47e-06	3.72e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—DRD2—bipolar disorder	6.46e-06	3.71e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—ADCY2—bipolar disorder	6.45e-06	3.7e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—DRD2—bipolar disorder	6.44e-06	3.7e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—HTR2A—bipolar disorder	6.43e-06	3.69e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—ADCY2—bipolar disorder	6.43e-06	3.69e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TCF7L2—bipolar disorder	6.42e-06	3.69e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—DPYD—bipolar disorder	6.42e-06	3.69e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TCF7L2—bipolar disorder	6.41e-06	3.68e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—S100B—bipolar disorder	6.4e-06	3.68e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—CACNA1C—bipolar disorder	6.38e-06	3.67e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—DRD2—bipolar disorder	6.38e-06	3.66e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PIK3C2A—bipolar disorder	6.37e-06	3.66e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—DRD2—bipolar disorder	6.36e-06	3.65e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—DRD4—bipolar disorder	6.34e-06	3.65e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—S100B—bipolar disorder	6.3e-06	3.62e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	6.29e-06	3.61e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—POMC—bipolar disorder	6.25e-06	3.59e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—NCAN—bipolar disorder	6.23e-06	3.58e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PIK3C2A—bipolar disorder	6.22e-06	3.57e-05	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—POMC—bipolar disorder	6.16e-06	3.54e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—POMC—bipolar disorder	6.15e-06	3.53e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—POMC—bipolar disorder	6.14e-06	3.53e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—POMC—bipolar disorder	6.12e-06	3.52e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—COMT—bipolar disorder	6.12e-06	3.51e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—SLC5A3—bipolar disorder	6.1e-06	3.51e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—POMC—bipolar disorder	6.1e-06	3.5e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—MTHFR—bipolar disorder	6.09e-06	3.5e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—MAOA—bipolar disorder	6.07e-06	3.49e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—NRG1—bipolar disorder	6.05e-06	3.48e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—HTR2A—bipolar disorder	6.04e-06	3.47e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—POMC—bipolar disorder	6.04e-06	3.47e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—POMC—bipolar disorder	6.02e-06	3.46e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CACNA1C—bipolar disorder	6.02e-06	3.46e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—NTRK1—bipolar disorder	5.98e-06	3.43e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—ADCY2—bipolar disorder	5.97e-06	3.43e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CACNA1C—bipolar disorder	5.96e-06	3.43e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TCF7L2—bipolar disorder	5.95e-06	3.42e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—DRD2—bipolar disorder	5.91e-06	3.4e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—NTRK1—bipolar disorder	5.88e-06	3.38e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—NTRK1—bipolar disorder	5.87e-06	3.37e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	5.86e-06	3.37e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—NTRK1—bipolar disorder	5.85e-06	3.36e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—NRG1—bipolar disorder	5.84e-06	3.36e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—NTRK1—bipolar disorder	5.83e-06	3.35e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3C2A—bipolar disorder	5.81e-06	3.34e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—NRG1—bipolar disorder	5.81e-06	3.34e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—S100B—bipolar disorder	5.81e-06	3.34e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—NTRK1—bipolar disorder	5.78e-06	3.32e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—NTRK1—bipolar disorder	5.76e-06	3.31e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	5.73e-06	3.3e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—GSK3B—bipolar disorder	5.73e-06	3.29e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CLOCK—bipolar disorder	5.72e-06	3.29e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—S100B—bipolar disorder	5.72e-06	3.29e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—SNAP25—bipolar disorder	5.72e-06	3.28e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—S100B—bipolar disorder	5.71e-06	3.28e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—S100B—bipolar disorder	5.69e-06	3.27e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—POMC—bipolar disorder	5.68e-06	3.26e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—S100B—bipolar disorder	5.67e-06	3.26e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—NRG1—bipolar disorder	5.65e-06	3.25e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—INS—bipolar disorder	5.65e-06	3.25e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—S100B—bipolar disorder	5.61e-06	3.23e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—S100B—bipolar disorder	5.6e-06	3.22e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—POMC—bipolar disorder	5.6e-06	3.22e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—SNAP25—bipolar disorder	5.58e-06	3.21e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—TSHB—bipolar disorder	5.57e-06	3.2e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—TPH2—bipolar disorder	5.57e-06	3.2e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CACNB2—bipolar disorder	5.57e-06	3.2e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—NRG1—bipolar disorder	5.56e-06	3.2e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—DPYD—bipolar disorder	5.48e-06	3.15e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—HTR2A—bipolar disorder	5.46e-06	3.13e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—GSK3B—bipolar disorder	5.4e-06	3.1e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—MTHFR—bipolar disorder	5.39e-06	3.1e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—POMC—bipolar disorder	5.36e-06	3.08e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NTRK1—bipolar disorder	5.35e-06	3.07e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—INS—bipolar disorder	5.33e-06	3.06e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—HTR2A—bipolar disorder	5.27e-06	3.03e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—SNAP25—bipolar disorder	5.26e-06	3.02e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—HTR2A—bipolar disorder	5.24e-06	3.01e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—GSK3B—bipolar disorder	5.23e-06	3e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—SNAP25—bipolar disorder	5.21e-06	3e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—S100B—bipolar disorder	5.2e-06	2.99e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—POMC—bipolar disorder	5.19e-06	2.98e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—GSK3B—bipolar disorder	5.17e-06	2.97e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—INS—bipolar disorder	5.16e-06	2.96e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—POMC—bipolar disorder	5.13e-06	2.95e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—NRG1—bipolar disorder	5.13e-06	2.95e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—INS—bipolar disorder	5.1e-06	2.93e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CACNA1C—bipolar disorder	5.1e-06	2.93e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—HTR2A—bipolar disorder	5.1e-06	2.93e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—ADCY2—bipolar disorder	5.06e-06	2.91e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—NRG1—bipolar disorder	5.05e-06	2.9e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—NRG1—bipolar disorder	5.04e-06	2.89e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—NRG1—bipolar disorder	5.02e-06	2.88e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—HTR2A—bipolar disorder	5.02e-06	2.88e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—NRG1—bipolar disorder	5e-06	2.87e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3C2A—bipolar disorder	4.97e-06	2.85e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—NRG1—bipolar disorder	4.95e-06	2.85e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—MTHFR—bipolar disorder	4.94e-06	2.84e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—NRG1—bipolar disorder	4.94e-06	2.84e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—ADCY2—bipolar disorder	4.94e-06	2.84e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	4.9e-06	2.82e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—POMC—bipolar disorder	4.87e-06	2.8e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—GSK3B—bipolar disorder	4.87e-06	2.8e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—INS—bipolar disorder	4.84e-06	2.78e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—POMC—bipolar disorder	4.83e-06	2.77e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—INS—bipolar disorder	4.8e-06	2.76e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—ADCY2—bipolar disorder	4.65e-06	2.67e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—HTR2A—bipolar disorder	4.62e-06	2.66e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—ADCY2—bipolar disorder	4.61e-06	2.65e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NRG1—bipolar disorder	4.59e-06	2.64e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—HTR2A—bipolar disorder	4.54e-06	2.61e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—HTR2A—bipolar disorder	4.53e-06	2.6e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—HTR2A—bipolar disorder	4.51e-06	2.59e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—HTR2A—bipolar disorder	4.47e-06	2.57e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—HTR2A—bipolar disorder	4.46e-06	2.56e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—SNAP25—bipolar disorder	4.45e-06	2.56e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CLOCK—bipolar disorder	4.41e-06	2.54e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—GSK3B—bipolar disorder	4.39e-06	2.52e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—POMC—bipolar disorder	4.36e-06	2.5e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—INS—bipolar disorder	4.33e-06	2.49e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—COMT—bipolar disorder	4.33e-06	2.49e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—POMC—bipolar disorder	4.31e-06	2.48e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—MAOA—bipolar disorder	4.3e-06	2.47e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—TPH2—bipolar disorder	4.3e-06	2.47e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CACNB2—bipolar disorder	4.3e-06	2.47e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—TSHB—bipolar disorder	4.3e-06	2.47e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—INS—bipolar disorder	4.28e-06	2.46e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—GSK3B—bipolar disorder	4.24e-06	2.44e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—DPYD—bipolar disorder	4.23e-06	2.43e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—COMT—bipolar disorder	4.23e-06	2.43e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—GSK3B—bipolar disorder	4.22e-06	2.42e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—POMC—bipolar disorder	4.21e-06	2.42e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—MAOA—bipolar disorder	4.2e-06	2.41e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—POMC—bipolar disorder	4.18e-06	2.4e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—INS—bipolar disorder	4.18e-06	2.4e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—INS—bipolar disorder	4.16e-06	2.39e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—HTR2A—bipolar disorder	4.14e-06	2.38e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—GSK3B—bipolar disorder	4.1e-06	2.36e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—POMC—bipolar disorder	4.07e-06	2.34e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—INS—bipolar disorder	4.05e-06	2.33e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—GSK3B—bipolar disorder	4.04e-06	2.32e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—POMC—bipolar disorder	4.01e-06	2.3e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—COMT—bipolar disorder	3.99e-06	2.29e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—INS—bipolar disorder	3.98e-06	2.29e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—MAOA—bipolar disorder	3.96e-06	2.27e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—POMC—bipolar disorder	3.95e-06	2.27e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—COMT—bipolar disorder	3.95e-06	2.27e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—ADCY2—bipolar disorder	3.94e-06	2.27e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CACNA1C—bipolar disorder	3.93e-06	2.26e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—INS—bipolar disorder	3.93e-06	2.26e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—MAOA—bipolar disorder	3.92e-06	2.25e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	3.83e-06	2.2e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—GSK3B—bipolar disorder	3.72e-06	2.14e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—POMC—bipolar disorder	3.69e-06	2.12e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—INS—bipolar disorder	3.67e-06	2.11e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—GSK3B—bipolar disorder	3.66e-06	2.1e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—GSK3B—bipolar disorder	3.66e-06	2.1e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—GSK3B—bipolar disorder	3.64e-06	2.09e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—POMC—bipolar disorder	3.63e-06	2.09e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—GSK3B—bipolar disorder	3.63e-06	2.09e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—POMC—bipolar disorder	3.63e-06	2.08e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—POMC—bipolar disorder	3.61e-06	2.08e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—INS—bipolar disorder	3.61e-06	2.08e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—INS—bipolar disorder	3.61e-06	2.07e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—POMC—bipolar disorder	3.6e-06	2.07e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—GSK3B—bipolar disorder	3.6e-06	2.07e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—INS—bipolar disorder	3.59e-06	2.07e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—GSK3B—bipolar disorder	3.59e-06	2.06e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—INS—bipolar disorder	3.58e-06	2.06e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—POMC—bipolar disorder	3.57e-06	2.05e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—POMC—bipolar disorder	3.56e-06	2.04e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—INS—bipolar disorder	3.55e-06	2.04e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—INS—bipolar disorder	3.54e-06	2.03e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—MTHFR—bipolar disorder	3.5e-06	2.01e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—SNAP25—bipolar disorder	3.44e-06	1.98e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—MTHFR—bipolar disorder	3.42e-06	1.96e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—COMT—bipolar disorder	3.38e-06	1.94e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—MAOA—bipolar disorder	3.35e-06	1.93e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—GSK3B—bipolar disorder	3.33e-06	1.91e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—POMC—bipolar disorder	3.31e-06	1.9e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—INS—bipolar disorder	3.29e-06	1.89e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—MTHFR—bipolar disorder	3.22e-06	1.85e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—MTHFR—bipolar disorder	3.19e-06	1.83e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ADCY2—bipolar disorder	3.04e-06	1.75e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—POMC—bipolar disorder	2.8e-06	1.61e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—INS—bipolar disorder	2.79e-06	1.6e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—POMC—bipolar disorder	2.73e-06	1.57e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—MTHFR—bipolar disorder	2.73e-06	1.57e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—INS—bipolar disorder	2.72e-06	1.56e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—COMT—bipolar disorder	2.61e-06	1.5e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—MAOA—bipolar disorder	2.59e-06	1.49e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—POMC—bipolar disorder	2.58e-06	1.48e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—INS—bipolar disorder	2.56e-06	1.47e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—POMC—bipolar disorder	2.55e-06	1.47e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—INS—bipolar disorder	2.54e-06	1.46e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—POMC—bipolar disorder	2.18e-06	1.25e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—INS—bipolar disorder	2.17e-06	1.25e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—MTHFR—bipolar disorder	2.11e-06	1.21e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—POMC—bipolar disorder	1.68e-06	9.68e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—INS—bipolar disorder	1.68e-06	9.62e-06	CbGpPWpGaD
